A detailed history of Orion Portfolio Solutions, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 11,553 shares of ARDX stock, worth $55,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,553
Previous 13,387 13.7%
Holding current value
$55,454
Previous $99,000 20.2%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$5.28 - $7.57 $9,683 - $13,883
-1,834 Reduced 13.7%
11,553 $79,000
Q2 2024

Aug 13, 2024

SELL
$5.89 - $9.31 $217 - $344
-37 Reduced 0.28%
13,387 $99,000
Q1 2024

May 09, 2024

BUY
$6.05 - $9.74 $11,452 - $18,437
1,893 Added 16.42%
13,424 $97,000
Q4 2023

Feb 09, 2024

BUY
$3.29 - $6.64 $37,936 - $76,565
11,531 New
11,531 $71,000
Q2 2022

Jul 14, 2022

BUY
$0.51 - $1.17 $12,889 - $29,570
25,274 New
25,274 $15,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $742M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.